What factors and medications affect COVID-19 complications and mortality in patients with diabetes?
Read More »What Might Be Better Than CGM?
Saliva testing may be able to provide an alternative form of glucose management.
Read More »Dealing with Difficult Patients
Ricardo, a 35-year-old man, newly diagnosed with type 1 diabetes, was hospitalized for diabetic ketoacidosis (DKA). Once he was stabilized, he wanted to go home. He refused to learn how to self-administer insulin. However, he was told he would not be discharged until he self-administered insulin, at least one time....
Read More »Latino Culture-Specific Shared Medical Appointments
A study in California highlights the importance of addressing cultural and structural barriers in implementing shared medical appointments.
Read More »Following the Effects of COVID-19 Quarantine on Glucose Management
With stay-at-home orders, daily routines for many diabetes patients have been disrupted, creating concerns over the possible consequences of added stress, isolation, and elevated blood sugars.
Read More »A New Diabetes Drug Class
Imeglimin, a new, first-in-class blood-glucose-lowering agent, proves to be safe and efficient as monotherapy and adjunctive therapy to lower A1C in patients with type 2 diabetes.
Read More »Comparing Long-Term HbA1C Variability with All-Cause Mortality in the ACCORD Trial
Study shows that visit-to-visit HbA1C variability can have significant effects on the prognosis for patients living with diabetes.
Read More »Exercise Not Guaranteed to Lower Blood Glucose
John, a gentleman in his 70's who has diabetes, always visited my group after he exercised. I noticed he always had something (hard candy) in his mouth and he seemed tired. I asked him why he was doing this candy thing. He said, "After exercise I like to refresh my breath, and want to make sure I prevent a low blood sugar...."
Read More »The Effect of HbA1c Variability on Cardiovascular Disease
The new HbA1c variability score (HVS) allows HbA1c variability to be more easily and consistently studied.
Read More »Length and Link of Hemoglobin A1C, Cardiovascular Events, and Type 2 Diabetes
The familiarity of using hemoglobin A1C value to guide control in patients with type 2 diabetes is known, but how do these longitudinal values relate to cardiovascular outcomes?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.